These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7883099)

  • 1. Consistency and stability of recombinant fermentations.
    Wiebe ME; Builder SE
    Dev Biol Stand; 1994; 83():45-54. PubMed ID: 7883099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fermentation on product consistency.
    Lubiniecki AS; Anumula K; Callaway J; L'Italien J; Oka M; Okita B; Wasserman G; Zabriskie D; Arathoon R; Builder S
    Dev Biol Stand; 1992; 76():105-15. PubMed ID: 1478331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic stability of protein expression systems in yeast.
    Bussineau CM; Shuster JR
    Dev Biol Stand; 1994; 83():13-9. PubMed ID: 7883086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and phenotypic markers and their relationship to product quality and consistency.
    Adamson SR; Charlebois TS
    Dev Biol Stand; 1994; 83():31-44. PubMed ID: 7883098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide mapping for detecting variants in protein products.
    Garnick RL
    Dev Biol Stand; 1992; 76():117-30. PubMed ID: 1478332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing genetic stability at the nucleic acid level.
    Galibert F
    Dev Biol Stand; 1994; 83():27-30. PubMed ID: 7883096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of biotechnological production processes.
    Werner RG; Langlouis-Gau H; Walz F; Allgaier H; Hoffmann H
    Arzneimittelforschung; 1988 Jun; 38(6):855-62. PubMed ID: 3052464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical strategies for the determination of protein modifications.
    Janis LJ; Davis GC
    Dev Biol Stand; 1994; 83():135-42. PubMed ID: 7883087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene stability in mammalian cells and protein consistency.
    Berthold W
    Dev Biol Stand; 1994; 83():67-79. PubMed ID: 7883100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic stability and recombinant product consistency.
    Lubiniecki AS
    Dev Biol Stand; 1994; 83():3-6. PubMed ID: 7883097
    [No Abstract]   [Full Text] [Related]  

  • 12. Ensuring the consistency of rDNA-derived biologicals: the contribution of gene sequencing.
    Griffiths E
    Dev Biol Stand; 1994; 83():179-82. PubMed ID: 7883093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting the regulatory requirements for pharmaceutical production of recombinant DNA derived products.
    Werner RG; Langlouis-Gau H
    Arzneimittelforschung; 1989 Jan; 39(1):108-11. PubMed ID: 2719737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic stability of rDNA production systems, a case report.
    Chiu YY
    Dev Biol Stand; 1994; 83():93-7. PubMed ID: 7883104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography.
    Johnson C; Royal M; Moreadith R; Bedu-Addo F; Advant S; Wan M; Conn G
    Biomed Chromatogr; 2003 Jul; 17(5):335-44. PubMed ID: 12884399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
    Hatfield GW; Roth DA
    Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical considerations in the development of protein purification processes.
    Anicetti V; Hancock WS
    Bioprocess Technol; 1994; 18():11-36. PubMed ID: 7764169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian cell cultures. Part II: Genetic engineering, protein glycosylation, fermentation and process control.
    Werner RG; Noé W
    Arzneimittelforschung; 1993 Nov; 43(11):1242-9. PubMed ID: 8292072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic stability and recombinant product consistency.
    Burstyn D; Copmann T; Dinowitz M; Garnick R; Losikoff A; Lubiniecki A; Wiebe M
    Biologicals; 1993 Jun; 21(2):147-9. PubMed ID: 8297595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of protein production from recombinant mammalian cells.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Bioeng; 2003 Mar; 81(6):631-9. PubMed ID: 12529877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.